GlycoMimetics Inc (NAS:GLYC)
$ 0.39 -0.02 (-4.88%) Market Cap: 25.15 Mil Enterprise Value: 4.50 Mil PE Ratio: 0 PB Ratio: 1.26 GF Score: 30/100

Q2 2019 GlycoMimetics Inc Earnings Call Transcript

Aug 01, 2019 / 12:30PM GMT
Release Date Price: $9.25 (+0.22%)
Operator

Good morning, and thank you all for joining GlycoMimetics Second Quarter 2019 Conference Call. (Operator Instructions)

I would now like to turn the call over to Shari Annes of the Investor Relations Group at GlycoMimetics. Please go ahead.

Shari Annes;Annes Associates;Founder

Good morning. Today, we will highlight the key achievements of 2019 second quarter. The press release we issued this morning on our Q2 financials is available on the company's website at www.glycomimetics.com, under the Investors tab. This call is being recorded. A dial-in phone replay will be available for 24 hours after the close of the call. The webcast replay will also be available in the Investor Relations sections of the company's website for 30 days.

Joining me on the call today from GlycoMimetics are Rachel King, Chief Executive Officer; Brian Hahn, Senior VP and Chief Financial Officer; and Dr. Helen Thackray, Senior VP of Development and Chief Medical Officer.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot